Clinical practice guidelines and conflict of interest

CMAJ. 2005 Nov 22;173(11):1297, 1299. doi: 10.1503/cmaj.051423.
[Article in English, French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Canada
  • Conflict of Interest*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 2 / drug therapy
  • Drug Industry*
  • Expert Testimony
  • Humans
  • Hypoglycemic Agents / economics
  • Hypoglycemic Agents / therapeutic use
  • Insulin / analogs & derivatives
  • Insulin / economics
  • Insulin / therapeutic use
  • Insulin Glargine
  • Insulin, Long-Acting
  • Practice Guidelines as Topic*

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine